Pfizer

The European Medicines Agency (EMA) authorized this monday the application of booster dose of the coronavirus vaccines from Pfizer/BioNTech and Modern for people with immune problems. However, the decision to administer third doses to the rest of the population was left to the discretion of the different member states of the European Union.

This long-awaited recommendation comes after some countries, such as France and Germany, go ahead and launch their own booster campaigns, although countries have come to very different conclusions about who can get the extra dose.

In this way, the European Union se a a USA, United Kingdom e Israel, where regulatory bodies have already approved the use of Pfizer boosters, although there is no consensus among scientists on the breadth of their use. Israel is an outlier, as it recommends them for the entire population.

For the European regulator, people with a very weakened immune system should receive a third dose of Pfizer / BioNTech and Moderna vaccines, both based on messenger RNA or mRNA technology, “at least 28 days after the second”, Reuters reported.

The agency also explained that the appropriateness of a booster dose of Pfizer / BioNTech could be considered for adults with normal immune systems, around six months after the second dose, but added that “” the decision depends on each country.

“At the national level, public health agencies can issue official recommendations on the use of booster doses, taking into account new efficacy data and limited safety data,” he explained in a statement.

The World Health Organization (WHO) It has criticized rich countries for stockpiling coronavirus vaccines for their booster campaigns targeting broader population groups, while poorer nations have a hard time distributing even the first doses.

Disclaimer: If you need to update/edit/remove this news or article then please contact our support team Learn more

Leave a Reply